HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 81 filers reported holding HARPOON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $116,000 | -59.7% | 14,703 | -15.1% | 0.00% | -100.0% |
| Q4 2020 | $288,000 | -2.0% | 17,312 | +0.0% | 0.00% | -50.0% |
| Q3 2020 | $294,000 | -54.1% | 17,308 | -55.2% | 0.00% | -60.0% |
| Q2 2020 | $641,000 | -18.1% | 38,622 | -42.9% | 0.01% | -50.0% |
| Q1 2020 | $783,000 | +58.8% | 67,630 | +103.0% | 0.02% | +566.7% |
| Q4 2019 | $493,000 | – | 33,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |